⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SMMT News
Summit Therapeutics Inc. Common Stock
Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm
prnewswire.com
SMMT
Form 8-K
sec.gov
SMMT
Form 8-K
sec.gov
SMMT
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
businesswire.com
SMMT
Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
businesswire.com
SMMT
RCUS
Form 8-K
sec.gov
SMMT
Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study
businesswire.com
SMMT
Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm
globenewswire.com
SMMT
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
globenewswire.com
BNTX
SMMT
CGON
NTHI
Form 8-K
sec.gov
SMMT